L020.F BRITANNIA LIFE SCIENCES

Healthcare Biotechnology Frankfurt Exchange
0.0295 EUR
Close of Nov 12, 2026
0.0225 0.0515
Market cap
EUR 4.86M
P/E
0.4x
P/B
0.35x
ROE
21.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is L020.F undervalued?

Graham number

The Graham number of BRITANNIA LIFE SCIENCES cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BRITANNIA LIFE SCIENCES fundamental analysis

No fundamental analysis for BRITANNIA LIFE SCIENCES yet.

BRITANNIA LIFE SCIENCES stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BRITANNIA LIFE SCIENCES

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. The company serves cosmetics, consumer packaged and household goods, and nutraceutical industries. Britannia Life Sciences Inc. is headquartered in Toronto, Canada.

Full company profile